{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T23:02:01Z","timestamp":1792364521257,"version":"4.4.0"},"reference-count":74,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>Systemic lupus erythematosus (SLE) is a complex connective tissue disease that can potentially affect every organ of the human body. In some cases, SLE may present with diverse cardiac manifestations including pericarditis, myocarditis, valvular disease, atherosclerosis, thrombosis, and arrhythmias. Heart disease in SLE is associated with increased morbidity and mortality. It is unclear whether traditional treatments for coronary artery disease significantly impact mortality in this population. Current therapeutic agents for SLE include glucocorticoids, hydroxychloroquine, mycophenolate mofetil, azathioprine, methotrexate, cyclophosphamide, and B cell-directed therapies. This article will provide a comprehensive review and update on this important disease state.<\/jats:p>","DOI":"10.1097\/crd.0000000000000358","type":"journal-article","created":{"date-parts":[[2020,9,29]],"date-time":"2020-09-29T08:59:57Z","timestamp":1601369997000},"page":"38-43","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":42,"title":["Cardiac Manifestations of Systemic Lupus Erythematous: An Overview of the Incidence, Risk Factors, Diagnostic Criteria, Pathophysiology and Treatment Options"],"prefix":"10.1097","volume":"30","author":[{"given":"Nicole K.","family":"Zagelbaum Ward","sequence":"first","affiliation":[{"name":"Department of Rheumatology, Keck School of Medicine\/University of Southern California, Los Angeles, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Linares-Koloffon","sequence":"additional","affiliation":[{"name":"Yale Center for Asthma and Airway Disease, Yale University School of Medicine, New Haven, CT"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Posligua","sequence":"additional","affiliation":[{"name":"Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliya","family":"Gandrabur","sequence":"additional","affiliation":[{"name":"Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woo Young","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk","family":"Sperber","sequence":"additional","affiliation":[{"name":"Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Wasserman","sequence":"additional","affiliation":[{"name":"Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Ash","sequence":"additional","affiliation":[{"name":"Department of Medicine and Division of Rheumatology, Westchester Medical Center and New York Medical College, Valhalla, NY."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,3]]},"reference":[{"key":"R1-20250619","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1136\/jcp.2009.064311","article-title":"Cardiac pathology of systemic lupus erythematosus.","volume":"62","author":"Jain","year":"2009","journal-title":"J Clin Pathol"},{"key":"R2-20250619","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1093\/rheumatology\/kex260","article-title":"The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies.","volume":"56","author":"Rees","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"R3-20250619","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4065\/74.3.275","article-title":"Cardiac involvement in systemic lupus erythematosus.","volume":"74","author":"Moder","year":"1999","journal-title":"Mayo Clin Proc"},{"key":"R4-20250619","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11926-016-0571-2","article-title":"Mortality in systemic lupus erythematosus: an updated review.","volume":"18","author":"Fors Nieves","year":"2016","journal-title":"Curr Rheumatol Rep"},{"key":"R5-20250619","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0002-8703(64)90248-0","article-title":"The cardiovascular manifestations of systemic lupus erythematosus.","volume":"68","author":"Hejtmancik","year":"1964","journal-title":"Am Heart J"},{"key":"R6-20250619","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1556-4029.2010.01683.x","article-title":"Lethal manifestations of systemic lupus erythematosus in a forensic context.","volume":"56","author":"Nicklin","year":"2011","journal-title":"J Forensic Sci"},{"key":"R7-20250619","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.tcm.2017.08.015","article-title":"Heart failure in systemic lupus erythematosus.","volume":"28","author":"Dhakal","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"R8-20250619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/hrt.22.1.1","article-title":"The heart in systemic lupus erythematosus.","volume":"22","author":"Brigden","year":"1960","journal-title":"Br Heart J"},{"key":"R9-20250619","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.rdc.2013.10.003","article-title":"Cardiac manifestations of systemic lupus erythematosus.","volume":"40","author":"Miner","year":"2014","journal-title":"Rheum Dis Clin North Am"},{"key":"R10-20250619","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2174\/1573397113666170704102444","article-title":"Cardiovascular and pulmonary manifestations of systemic lupus erythematosus.","volume":"13","author":"Tselios","year":"2017","journal-title":"Curr Rheumatol Rev"},{"issue":"suppl 4","key":"R11-20250619","doi-asserted-by":"crossref","first-page":"iv8","DOI":"10.1093\/rheumatology\/kel308","article-title":"Heart involvement in systemic lupus erythematosus, anti-phospholipid syndrome and neonatal lupus.","volume":"45","author":"Tincani","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"R12-20250619","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00251-013-0717-6","article-title":"TRAF3IP2 gene and systemic lupus erythematosus: association with disease susceptibility and pericarditis development.","volume":"65","author":"Perricone","year":"2013","journal-title":"Immunogenetics"},{"key":"R13-20250619","doi-asserted-by":"crossref","first-page":"e111991","DOI":"10.1371\/journal.pone.0111991","article-title":"A multilocus genetic study in a cohort of Italian SLE patients confirms the association with STAT4 gene and describes a new association with HCP5 gene.","volume":"9","author":"Ciccacci","year":"2014","journal-title":"PLoS One"},{"key":"R14-20250619","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/0961203316679528","article-title":"A polymorphism upstream MIR1279 gene is associated with pericarditis development in systemic lupus erythematosus and contributes to definition of a genetic risk profile for this complication.","volume":"26","author":"Ciccacci","year":"2017","journal-title":"Lupus"},{"key":"R15-20250619","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1191\/0961203305lu2200oa","article-title":"Cardiac involvement in systemic lupus erythematosus.","volume":"14","author":"Doria","year":"2005","journal-title":"Lupus"},{"key":"R16-20250619","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0889-857X(21)00951-0","article-title":"Cardiopulmonary manifestations of systemic lupus erythematous.","volume":"14","author":"Carette","year":"1988","journal-title":"Rheum Dis Clin North Am"},{"key":"R17-20250619","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1177\/0961203315593169","article-title":"Colchicine: a simple and effective treatment for pericarditis in systemic lupus erythematosus? A report of 10 cases.","volume":"24","author":"Morel","year":"2015","journal-title":"Lupus"},{"key":"R18-20250619","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.4103\/0366-6999.166029","article-title":"Lupus myocarditis: a Case-Control Study from China.","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"R19-20250619","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1191\/0961203305lu2228oa","article-title":"Acute lupus myocarditis: clinical features and outcome of an oriental case series.","volume":"14","author":"Law","year":"2005","journal-title":"Lupus"},{"key":"R20-20250619","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s10067-017-3971-4","article-title":"Lupus myocarditis receiving the rituximab therapy-a monocentric retrospective study.","volume":"37","author":"Wang","year":"2018","journal-title":"Clin Rheumatol"},{"key":"R21-20250619","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1136\/ard.2010.136762","article-title":"Lupus Atherosclerosis Prevention Study (LAPS).","volume":"70","author":"Petri","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R22-20250619","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/annrheumdis-2012-202315","article-title":"Secondary analysis of APPLE study suggests atorvastatin may reduce atherosclerosis progression in pubertal lupus patients with higher C reactive protein.","volume":"73","author":"Ardoin","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"R23-20250619","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1093\/rheumatology\/ket283","article-title":"Supervised physical exercise improves endothelial function in patients with systemic lupus erythematosus.","volume":"52","author":"dos Reis-Neto","year":"2013","journal-title":"Rheumatology (Oxford)"},{"key":"R24-20250619","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1182\/blood-2018-04-848333","article-title":"Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome.","volume":"132","author":"Pengo","year":"2018","journal-title":"Blood"},{"key":"R25-20250619","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/0961203315611495","article-title":"Efficacy and safety of rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome: rationale and design of the Trial on Rivaroxaban in AntiPhospholipid Syndrome (TRAPS) trial.","volume":"25","author":"Pengo","year":"2016","journal-title":"Lupus"},{"key":"R27-20250619","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1002\/art.21441","article-title":"Barriers to a trial of atherosclerosis prevention in systemic lupus erythematosus.","volume":"53","author":"Costenbader","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R28-20250619","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.hlc.2012.05.784","article-title":"Congenital complete heart block: single tertiary centre experience.","volume":"21","author":"Yan","year":"2012","journal-title":"Heart Lung Circ"},{"key":"R30-20250619","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1161\/CIRCULATIONAHA.107.707661","article-title":"Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.","volume":"117","author":"Friedman","year":"2008","journal-title":"Circulation"},{"key":"R31-20250619","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/art.27308","article-title":"Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: results of a multicenter, prospective, open-label clinical trial.","volume":"62","author":"Friedman","year":"2010","journal-title":"Arthritis Rheum"},{"key":"R32-20250619","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1177\/0961203310395800","article-title":"Acute lupus myocarditis: clinical features and outcome.","volume":"20","author":"Appenzeller","year":"2011","journal-title":"Lupus"},{"key":"R33-20250619","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3899\/jrheum.160493","article-title":"Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients.","volume":"44","author":"Thomas","year":"2017","journal-title":"J Rheumatol"},{"key":"R34-20250619","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases.","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"key":"R35-20250619","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/oxfordjournals.eurheartj.a061281","article-title":"Do endomyocardial biopsies represent the morphology of the rest of the myocardium? A quantitative light microscopic study of single v. multiple biopsies with the King\u2019s bioptome.","volume":"3","author":"Baandrup","year":"1982","journal-title":"Eur Heart J"},{"key":"R36-20250619","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0033-0620(85)90003-9","article-title":"Cardiovascular manifestations of systemic lupus erythematosus: current perspective.","volume":"27","author":"Ansari","year":"1985","journal-title":"Prog Cardiovasc Dis"},{"key":"R37-20250619","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0146-2806(99)90019-1","article-title":"The heart in systemic lupus erythematosus.","volume":"24","author":"Roberts","year":"1999","journal-title":"Curr Probl Cardiol"},{"key":"R38-20250619","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.semarthrit.2003.09.012","article-title":"Hydroxychloroquine cardiotoxicity in systemic lupus erythematosus: a report of 2 cases and review of the literature.","volume":"33","author":"Nord","year":"2004","journal-title":"Semin Arthritis Rheum"},{"key":"R39-20250619","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/01.CIR.3.4.492","article-title":"Acute and subacute disseminated lupus erythematosus; a correlation of clinical and postmortem findings in eighteen cases.","volume":"3","author":"Griffith","year":"1951","journal-title":"Circulation"},{"key":"R40-20250619","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.4103\/0366-6999.166029","article-title":"Lupus myocarditis: a case-control study from China.","volume":"128","author":"Zhang","year":"2015","journal-title":"Chin Med J (Engl)"},{"key":"R41-20250619","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","article-title":"Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution.","volume":"120","author":"Moyssakis","year":"2007","journal-title":"Am J Med"},{"key":"R42-20250619","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.autrev.2016.09.007","article-title":"Prevalence and predictors of valvular heart disease in patients with systemic lupus erythematosus.","volume":"15","author":"Vivero","year":"2016","journal-title":"Autoimmun Rev"},{"key":"R43-20250619","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/art.21162","article-title":"Severe valvular regurgitation and antiphospholipid antibodies in systemic lupus erythematosus: a prospective, long-term, followup study.","volume":"53","author":"Perez-Villa","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R44-20250619","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/heartjnl-2016-309561","article-title":"Incidence and risk of heart failure in systemic lupus erythematosus.","volume":"103","author":"Kim","year":"2017","journal-title":"Heart"},{"key":"R45-20250619","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1007\/s11926-009-0035-z","article-title":"Epidemiology of atherosclerosis in systemic lupus erythematosus.","volume":"11","author":"Nikpour","year":"2009","journal-title":"Curr Rheumatol Rep"},{"key":"R46-20250619","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2174\/157340308784245775","article-title":"Cardiovascular disease in systemic lupus erythematosus: the role of traditional and lupus related risk factors.","volume":"4","author":"Zeller","year":"2008","journal-title":"Curr Cardiol Rev"},{"key":"R47-20250619","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus.","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R48-20250619","first-page":"288","article-title":"Single photon emission computed tomography dual isotope myocardial perfusion imaging in women with systemic lupus erythematosus. II. Predictive factors for perfusion abnormalities.","volume":"30","author":"Bruce","year":"2003","journal-title":"J Rheumatol"},{"key":"R49-20250619","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1093\/aje\/kws130","article-title":"Incidence of and risk factors for adverse cardiovascular events among patients with systemic lupus erythematosus.","volume":"176","author":"Magder","year":"2012","journal-title":"Am J Epidemiol"},{"key":"R50-20250619","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study.","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"R51-20250619","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1161\/hc0902.104353","article-title":"Inflammation and atherosclerosis.","volume":"105","author":"Libby","year":"2002","journal-title":"Circulation"},{"key":"R52-20250619","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.berh.2017.09.012","article-title":"Atherosclerosis in systemic lupus erythematosus.","volume":"31","author":"Croca","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"R53-20250619","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1080\/07853890510007322","article-title":"The double jeopardy of HDL.","volume":"37","author":"Navab","year":"2005","journal-title":"Ann Med"},{"key":"R54-20250619","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1177\/0961203316671810","article-title":"Complementary role of cardiovascular imaging and laboratory indices in early detection of cardiovascular disease in systemic lupus erythematosus.","volume":"26","author":"Mavrogeni","year":"2017","journal-title":"Lupus"},{"key":"R55-20250619","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1093\/rheumatology\/kev198","article-title":"Coronary calcification in SLE: comparison with the multi-ethnic study of atherosclerosis.","volume":"54","author":"Kiani","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R56-20250619","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/0961203308090020","article-title":"The innate immune system in SLE: type I interferons and dendritic cells.","volume":"17","author":"R\u00f6nnblom","year":"2008","journal-title":"Lupus"},{"key":"R57-20250619","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/BOR.0000000000000087","article-title":"Advances in understanding the role of type I interferons in systemic lupus erythematosus.","volume":"26","author":"Crow","year":"2014","journal-title":"Curr Opin Rheumatol"},{"key":"R58-20250619","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/hq1201.100220","article-title":"Immune mechanisms in atherosclerosis.","volume":"21","author":"Hansson","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"R59-20250619","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1586\/eci.10.98","article-title":"Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.","volume":"7","author":"McMahon","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"R60-20250619","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1111\/joim.12357","article-title":"Pathogenic immunity in systemic lupus erythematosus and atherosclerosis: common mechanisms and possible targets for intervention.","volume":"278","author":"Wigren","year":"2015","journal-title":"J Intern Med"},{"key":"R61-20250619","first-page":"43","article-title":"Circulating markers of inflammation are related to carotid artery atherosclerosis.","volume":"24","author":"Larsson","year":"2005","journal-title":"Int Angiol"},{"key":"R62-20250619","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1097-2765(00)80139-2","article-title":"Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice.","volume":"2","author":"Gu","year":"1998","journal-title":"Mol Cell"},{"key":"R63-20250619","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis.","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat Immunol"},{"key":"R64-20250619","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1172\/JCI119465","article-title":"IFN-gamma potentiates atherosclerosis in ApoE knock-out mice.","volume":"99","author":"Gupta","year":"1997","journal-title":"J Clin Invest"},{"key":"R65-20250619","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0002-9440(10)64820-1","article-title":"Exogenous interferon-gamma enhances atherosclerosis in apolipoprotein E-\/- mice.","volume":"157","author":"Whitman","year":"2000","journal-title":"Am J Pathol"},{"key":"R66-20250619","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2012.14","article-title":"Accelerated atherosclerosis in patients with SLE\u2013mechanisms and management.","volume":"8","author":"Skaggs","year":"2012","journal-title":"Nat Rev Rheumatol"},{"key":"R67-20250619","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1097\/BOR.0b013e328349a255","article-title":"Effector T-cell subsets in systemic lupus erythematosus: update focusing on Th17 cells.","volume":"23","author":"Shin","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R68-20250619","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/FJC.0b013e31829dd857","article-title":"Atherosclerosis in systemic lupus erythematosus.","volume":"62","author":"Stojan","year":"2013","journal-title":"J Cardiovasc Pharmacol"},{"key":"R69-20250619","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.1182\/blood-2003-09-3198","article-title":"Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity.","volume":"103","author":"Rajagopalan","year":"2004","journal-title":"Blood"},{"key":"R70-20250619","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"R71-20250619","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa035611","article-title":"Premature coronary-artery atherosclerosis in systemic lupus erythematosus.","volume":"349","author":"Asanuma","year":"2003","journal-title":"N Engl J Med"},{"key":"R72-20250619","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood-2008-03-144204","article-title":"Hydroxychloroquine directly reduces the binding of antiphospholipid antibody-beta2-glycoprotein I complexes to phospholipid bilayers.","volume":"112","author":"Rand","year":"2008","journal-title":"Blood"},{"key":"R73-20250619","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/rheumatology\/keu451","article-title":"Hydroxychloroquine reduces risk of incident diabetes mellitus in lupus patients in a dose-dependent manner: a population-based cohort study.","volume":"54","author":"Chen","year":"2015","journal-title":"Rheumatology (Oxford)"},{"key":"R74-20250619","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s100249900017","article-title":"Congenital heart block and associated cardiac pathology in neonatal lupus syndrome.","volume":"1","author":"Meckler","year":"1998","journal-title":"Pediatr Dev Pathol"},{"key":"R75-20250619","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/CRD.0000000000000026","article-title":"Prevention and treatment in utero of autoimmune-associated congenital heart block.","volume":"22","author":"Saxena","year":"2014","journal-title":"Cardiol Rev"},{"key":"R76-20250619","first-page":"36","article-title":"A review of congenital heart block.","volume":"5","author":"Friedman","year":"2003","journal-title":"Images Paediatr Cardiol"}],"container-title":["Cardiology in Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000358","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:01:10Z","timestamp":1750341670000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/CRD.0000000000000358"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,3]]},"references-count":74,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/crd.0000000000000358","relation":{},"ISSN":["1061-5377"],"issn-type":[{"value":"1061-5377","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,3]]}}}